Ligaya G Magbanua

Title: Ligaya G. Magbanua: Innovator in Anti-Allergic Compounds

Introduction

Ligaya G. Magbanua is a notable inventor based in Allentown, NJ (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-allergic compositions. Her work has led to the creation of innovative compounds that have potential therapeutic applications.

Latest Patents

Magbanua holds a patent for "Thioxopyrazolo[1,5-c]quinazoline derivatives, anti-allergic compositions." This patent includes compounds characterized by specific structural features, where R¹ can be hydrogen or a lower alkyl group of 1-3 carbons. R² is defined as carboxyl, hydroxymethyl, lower alkanoyloxymethyl, or lower alkoxycarbonyl. Additionally, R³ can be hydrogen, lower alkyl, or benzyl, while R⁴ and R⁵ can represent various functional groups. These compounds are particularly useful as anti-allergics when administered parenterally or by insufflation, although they exhibit poor activity when taken orally.

Career Highlights

Ligaya G. Magbanua is associated with E.R. Squibb & Sons, Inc., where she has contributed her expertise in pharmaceutical research and development. Her innovative work has positioned her as a key figure in the advancement of anti-allergic therapies.

Collaborations

Magbanua has collaborated with B. Richard Vogt, enhancing her research efforts and contributing to the development of new therapeutic solutions.

Conclusion

Ligaya G. Magbanua's contributions to the field of anti-allergic compositions highlight her innovative spirit and dedication to improving healthcare. Her patent reflects her commitment to advancing pharmaceutical science and addressing the needs of patients suffering from allergies.